Main navigation
Search Results
-
Reports, magazines, Biotech Guide ... https://www.bio-pro.de/en/information/publications -
Innovation for sustainable plastic packaging - 04/09/2024 Liquid Plug & Play: eco-designed plastic packaging – not just for ultrasound gel
In the healthcare industry tons of consumables such as ultrasound gel go to waste because packaging can’t be completely emptied. An invention called Liquid Plug & Play could offer a solution for the future. This innovation, which consists of a reusable outer shell and a disposable product pouch for viscous substances, can be completely emptied. It also prevents cross-contamination and offers many other benefits.
https://www.gesundheitsindustrie-bw.de/en/article/news/liquid-plug-und-play-eco-designed-plastic-packaging-not-just-ultrasound-gel -
EU-wide networking of innovation ecosystems for personalised healthcare https://www.bio-pro.de/en/projects/current-projects/preciseu-personalised-medicine-empowerment-connecting-innovation-ecosystems-across-europePRECISEU - PeRsonalised medicine Empowerment Connecting Innovation ecoSystems across EUrope
-
Event - The TechMed Event 2024
TechMed Centre , Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/techmed-event-2024 -
Event - MedTech Twente Week: Explore & Connect fact-finding trip
Enschede, Netherlands , Fact-finding triphttps://www.gesundheitsindustrie-bw.de/en/event/medtech-twente-week-explore-und-connect-fact-finding-trip -
Press release - 26/08/2024 Synthetic Immunology: Approaching a Turning Point in the Treatment and Prevention of Disease
Synthetic immunology is the topic of an article in the “Perspectives” section of the journal “Nature Nanotechnology”. Herein, Heidelberg researchers describe a so-called bottom-up approach that uses the toolbox of nanotechnology and synthetic biology to construct systems from molecular building blocks and specifically equip them with immune functions.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/synthetic-immunology-approaching-turning-point-treatment-and-prevention-disease -
Press release - 21/08/2024 A molecular control hub maintains order
How are proteins in our cells modified while they are still being synthesized? An international team of researchers from the University of Konstanz, Caltech, and ETH Zurich has deciphered the molecular mechanism of this vital process.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-control-hub-maintains-order -
Press release - 22/08/2024 Validated targets for personalized cancer immunotherapy
Knowledge of the target structures for the immune cells is a basic prerequisite for the development of personalized cancer immunotherapies. Scientists from the German Cancer Research Center and the NCT Heidelberg are publishing a sensitive method based on mass spectroscopy to identify such tumor-specific "neoepitopes". The analytical method is designed to detect these low abundance protein fragments and requires minimal amounts of…
https://www.gesundheitsindustrie-bw.de/en/article/press-release/validated-targets-personalized-cancer-immunotherapy -
Press release - 04/09/2024 Epigenetic changes reprogram astrocytes into brain stem cells
With mice, researchers showed that experimentally induced lack of blood flow in the brain epigenetically reprograms astrocytes into brain stem cells, which in turn can give rise to nerve progenitor cells. This discovery shows that astrocytes could potentially be used in regenerative medicine to replace damaged nerve cells.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/epigenetic-changes-reprogram-astrocytes-brain-stem-cells -
BIOPRO Baden-Württemberg publishes first results of a new WifOR study - 11/09/2024 Industrial healthcare industry in Baden-Württemberg: gross value added of more than 19 billion euros
The industrial healthcare sector (iGW) plays a central role in the economy in Baden-Württemberg. In 2021, the sector generated a direct gross value added of 19.6 billion euros, which corresponds to around a third (32.6%) of the entire regional healthcare industry. Of 96.3%, almost all of the healthcare sectors's exports in the state in 2021 came from the iGW. These are the findings of a new study conducted on behalf of BIOPRO…
https://www.gesundheitsindustrie-bw.de/en/article/press-release/industrial-healthcare-industry-baden-wuerttemberg-gross-value-added-more-19-billion-euros -
BIOPRO Baden-Württemberg publishes first results of a new WifOR study - 11/09/2024 Industrial healthcare industry in Baden-Württemberg: gross value added of more than 19 billion euros
The industrial healthcare sector (iGW) plays a central role in the economy in Baden-Württemberg. In 2021, the sector generated a direct gross value added of 19.6 billion euros, which corresponds to around a third (32.6%) of the entire regional healthcare industry. Of 96.3%, almost all of the healthcare sectors's exports in the state in 2021 came from the iGW. These are the findings of a new study conducted on behalf of BIOPRO…
https://www.bio-pro.de/en/information/press-release/industrial-healthcare-industry-baden-wuerttemberg-gross-value-added-more-19-billion-euros -
Press release - 09/09/2024 New Molecular Engineering Technique allows for complex Organoids
A new molecular engineering technique can precisely influence the development of organoids. Microbeads made of specifically folded DNA are used to release growth factors or other signal molecules inside the tissue structures. This gives rise to considerably more complex organoids that imitate the respective tissues much better and have a more realistic cell mix than before.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-molecular-engineering-technique-allows-complex-organoids -
Press release - 05/09/2024 Cohesion at the cellular level: flexible yet stable
Research teams from the Universities of Konstanz and Potsdam are analyzing how proteins work together to enable our cells to both stick and move. The marker protein paxillin is at the centre of their interest.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/cohesion-cellular-level-flexible-yet-stable -
Press release - 03/09/2024 NMR Spectroscopy: A Faster Way to Determine the “Sense of Rotation” of Molecules
Researchers of Karlsruhe Institute of Technology (KIT) and Voxalytic GmbH developed a new method that allows, for the first time, to elucidate the chiral structure of molecules – the exact spatial arrangement of the atoms – by nuclear magnetic resonance (NMR) spectroscopy. This important step in the development of new drugs used to be a time-consuming process until now.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/nmr-spectroscopy-faster-way-determine-sense-rotation-molecules -
Vaccine development - 25/05/2021 Vaccines - a beacon of hope in the fight against pandemics
Having long been considered less lucrative for the big pharmaceutical companies, vaccine development is taking off in an unforeseen way in the wake of the COVID-19 pandemic. Financial support is flooding in and all kinds of vaccine development strategies are being deployed. Among the winners in the competition for effective coronavirus vaccines are vaccines based on RNA technology.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/vaccines-beacon-hope-fight-against-pandemics -
Dossier - 02/12/2013 RNA interference confidence is returning
The 15-year history of RNA interference is not short on dramatic effects. It begins with the unexpected discovery and publication of the process of post-transcriptional gene silencing in 1998 for which Andrew Fire and Craig Mello were awarded the Nobel Prize in Physiology or Medicine just eight years after their discovery. In 2001 Thomas Tuschl succeeded in switching off genes in human cells with small synthetic pieces of RNA siRNA.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/rna-interference-confidence-is-returning -
Dossier - 10/11/2014 Cell and gene therapies from bench to bedside
While cell therapy has become standard treatment for a number of blood cancers, most cell and gene therapy approaches for the treatment of hereditary and metabolic diseases, neurodegenerative disorders and cancer are still in the experimental phases or early clinical trials. However, recent successes give rise to the hope that cell and gene therapies will in future make important contributions to previously incurable diseases.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/cell-and-gene-therapies-from-bench-to-bedside -
Press release - 12/09/2024 Power-to-vitamins: microbes produce folate from simple basic ingredients
Biotechnology team at University of Tübingen obtains valuable byproduct in protein production. This could be a potential to the contribution of feeding a growing world population without livestock farming.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/power-vitamins-microbes-produce-folate-simple-basic-ingredients -
Press release - 11/09/2024 Researchers combine the power of artificial intelligence and the wiring diagram of a brain to predict brain cell activity
Scientists have long sought ways to simulate the neural networks in the brain with computers in order to understand how it works. Now, researchers have combined new measurements of the wiring diagrams of the fruit fly with artificial intelligence methods to build a neural network that can do what few thought possible: To predict the activity of individual neurons without making a single measurement in a living brain.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/researchers-combine-power-artificial-intelligence-and-wiring-diagram-brain-predict-brain-cell-activity -
Press release - 17/09/2024 Five new cross-border doctoral networks at Universität Heidelberg
Five transnational and cross-institutional doctoral networks at Heidelberg University are being funded as part of the “Marie Skłodowska-Curie Actions”. They work together on current scientific topics with high innovation potential. Ruperto Carola coordinates an MSCA Doctoral Network on artificial intelligence in physics, two networks in medicine, life sciences and engineering.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/five-new-cross-border-doctoral-networks-universitat-heidelberg -
Press release - 18/09/2024 Future cluster QSens starts the second round of funding
In the “Cluster4Future” QSens of the Universities of Stuttgart and Ulm, scientists, companies and start-ups are researching quantum sensors with a wide range of potential applications. The Federal Ministry of Education and Research is funding QSens for a further three years as part of “Clusters4Future”.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/future-cluster-qsens-starts-second-round-funding -
Chronic inflammatory bowel diseases - 25/09/2024 Proinflammatory regulatory T lymphocytes as a therapeutic target in Crohn's disease
Chronic inflammatory bowel diseases are very stressful for those affected and increase the risk of bowel cancer. PD Dr. Robyn Laura Kosinsky from the Bosch Health Campus in Stuttgart, together with researchers from the USA, identified disfunctional regulatory T cells as important drivers of inflammation in Crohn's disease. They also found that with the help of an epigenetically active drug, it was possible to restore the cells’ original…
https://www.gesundheitsindustrie-bw.de/en/article/news/proinflammatory-regulatory-t-lymphocytes-therapeutic-target-crohns-disease -
Press release - 25/09/2024 How developmental signals can contribute to Genomic Mosaicism
Certain developmental signals play a significant role in maintaining our genetic blueprints. They prevent alterations in the genome, known as mosaicism. The underlying biological mechanism helps the DNA to produce an identical copy of itself during cell division using the original genetic blueprint. However, it can also contribute to genomic mosaicism during nerve cell development.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-developmental-signals-can-contribute-genomic-mosaicism -
Press release - 25/09/2024 How do rare genetic variants affect health? AI provides more accurate predictions
Whether we are predisposed to particular diseases depends to a large extent on the countless variants in our genome. However in the case of genetic variants the influence on the presentation of certain pathological traits has been difficult to determine. Researchers have introduced an algorithm based on deep learning that can predict the effects of rare genetic variants.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-do-rare-genetic-variants-affect-health-ai-provides-more-accurate-predictions -
Press release - 19/09/2024 Quality standards for looking into the tumor genome
Personalized medicine with individually tailored therapies is becoming more a reality in cancer. This requires a look into the genetic material of tumors, a molecular diagnostic tumor profile. A research group from the German Network for Personalized Medicine (DNPM) has recorded the quality standards according to which genome analyses are carried out in Germany. The data is a prerequisite for integrating gene sequencing into routine care.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/quality-standards-looking-tumor-genome -
Press release - 23/09/2024 Carl Zeiss Foundation supports early career research group for biohybrid neuroimplants
Dr Simon Binder has been awarded a five-year, 1.5 million euro grant from the Carl Zeiss Foundation for his research into novel neuroimplants. Binder will establish the early career research group ‘Biohybrid Neuroimplants based on Soft Hydrogel Electrodes’ at the University of Freiburg. It is affiliated with the research institutions BrainLinks-BrainTools.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/carl-zeiss-foundation-supports-early-career-research-group-biohybrid-neuroimplants -
-
Sustainable medical technology - 10/10/2024 Rethinking plastics in medical technology
Good healthcare relies heavily on medical products made from plastic. However, the widespread use of synthetic materials, particularly disposable items, creates vast amounts of waste, depletes resources and leads to a substantial carbon footprint. To create more environmentally friendly plastic products in the future, substantial changes to production processes are essential.
https://www.gesundheitsindustrie-bw.de/en/article/news/rethinking-plastics-medical-technology -
Press release - 01/10/2024 Reporter Skin: In-vitro Skin Makes Cell Reaction to Test Substance Measurable in Real Time
At the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, a three-dimensional skin model has now been set up for the first time that directly displays the skin's reaction to substances: The reporter skin. Thanks to the built-in reporter, the cellular response can be measured precisely and quickly – using a living model.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/reporter-skin-vitro-skin-makes-cell-reaction-test-substance-measurable-real-time -
Exploit opportunities, mastering challenges https://www.bio-pro.de/en/projects/current-projects/post-brexitPost-Brexit
-
Find the specialist you are looking for https://www.bio-pro.de/en/biopro/teamTeam
-
Press release - 09/10/2024 Language model "UroBot“ surpasses the accuracy of experienced urologists
Scientists at the German Cancer Research Center (DKFZ), together with doctors from the Urological Clinic of the Mannheim University Hospital, have developed and successfully tested a chatbot based on artificial intelligence. "UroBot" was able to answer questions from the urology specialist examination with a high degree of accuracy, surpassing both other language models and the accuracy of experienced urologists.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/language-model-urobot-surpasses-accuracy-experienced-urologists -
Event - Lunch & Learn: BW-UK Health Industry Procurement - Building Bridges for Better Healthcare
Online, Registration deadline: Informationsveranstaltunghttps://www.gesundheitsindustrie-bw.de/en/event/lunch-und-learn-bw-uk-health-industry-procurement-building-bridges-better-healthcare -
Event - Lunch & Learn: BW-UK Health Industry Procurement - Building Bridges for Better Healthcare
Online, Registration deadline: Informationsveranstaltunghttps://www.bio-pro.de/en/events/past-events/lunch-und-learn-bw-uk-health-industry-procurement-building-bridges-better-healthcare -
Press release - 16/10/2024 Sensitive Arm Prostheses
A quantum sensor that can register nerve impulses without contact opens up new possibilities in prosthetics. Researchers at Fraunhofer IPA are developing together with the industrial partner Q.ANT the prototype of one Prosthetic arm that is controlled by neural commands like healthy limbs.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/sensitive-arm-prostheses -
Save the date - Meet & Match - Gender Medicine: Biological insights and healthcare advances
Strasbourg (France) | CIARUS, Registration deadline: Meet & Matchhttps://www.gesundheitsindustrie-bw.de/en/event/meet-und-match-gender-medicine-biological-insights-and-healthcare-advances -
Save the date - Meet & Match - Gender Medicine: Biological insights and healthcare advances
Strasbourg (France) | CIARUS, Registration deadline: Meet & Matchhttps://www.bio-pro.de/en/events/meet-und-match-gender-medicine-biological-insights-and-healthcare-advances -
NMI project WOUNDSENS - 23/10/2024 Wound monitoring using sensory nanofibres
Monitoring the condition of chronic, non-healing wounds requires wound dressings to be changed at short, regular intervals. In the EU-funded WOUNDSENS project, researchers at the NMI in Reutlingen are using electrospinning to produce novel types of wound dressings. These consist of biosensory fibres that send information about the condition of the wound to the outside, thereby improving inflammation detection.
https://www.gesundheitsindustrie-bw.de/en/article/news/wound-monitoring-using-sensory-nanofibres -
Event - DIS&CO Health | Market opportunities in Morocco
Online , Registration deadline: Informationsveranstaltunghttps://www.gesundheitsindustrie-bw.de/en/event/dis-und-co-health-marktchancen-marokko -
Event - DIS&CO Health | Market opportunities in Morocco
Online , Registration deadline: Informationsveranstaltunghttps://www.bio-pro.de/en/events/dis-und-co-health-marktchancen-marokko -
Event - Networking Evening BW-UK | MEDICA 2024
MEDICA trade-fair, Baden-Württemberg joint-booth H09, Hall 14, Registration deadline: Messehttps://www.gesundheitsindustrie-bw.de/en/event/networking-abend-bw-uk-medica-2024 -
Event - Networking Evening BW-UK | MEDICA 2024
MEDICA trade-fair, Baden-Württemberg joint-booth H09, Hall 14, Registration deadline: Messehttps://www.bio-pro.de/en/events/networking-abend-bw-uk-medica-2024